The Chemours Company (CC) vs Ingevity Corporation (NGVT)
The Chemours Company and Ingevity Corporation are both Specialty Chemicals companies. Ingevity Corporation is the larger, with a market value of $2.5B against $2.1B — 1.2× the size. The Chemours Company has negative trailing earnings, so its P/E is not meaningful; Ingevity Corporation trades at 47.4×. Ingevity Corporation grew revenue faster over the last twelve months: 10.6% against −0.89%. Ingevity Corporation has the higher net margin (4.65% vs −5.24%) and the higher return on invested capital (9.33% vs −2.22%). Across the 19 metrics below, Ingevity Corporation leads on 12 and The Chemours Company on 7.
Valuation
Profitability
| Metric | CC | NGVT | Specialty Chemicals median |
|---|---|---|---|
| Gross margin | 15.28% | 41.13% | 29.23% |
| Operating margin | (1.93%) | 11.83% | 3.63% |
| Net margin | (5.24%) | 4.65% | 2.89% |
| Free cash flow margin | 3.76% | 13.35% | 3.78% |
| Return on equity | (318.32%) | 64.44% | 3.62% |
| Return on assets | (4.15%) | 3.16% | 0.35% |
| Return on invested capital | (2.22%) | 9.33% | 2.75% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack